
No Stock Yet
No Data
[encyclopedia of stocks] Pfizer Inc: multinational pharmaceutical giant
COVID vaccine stocks lead biotech selloff in 1H; three reasons to see recovery
Pure play COVID-19 vaccine makers closed the 1H 2022 as some of the worst performers in the beaten-down biotech space amid concerns over how the group, once a pandemic favorite, could sustain growth a
Pfizer Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. PFE sank 0.23% to $52.31 Friday, on what proved to be an all-around great tradi
Hot Stocks: Tickers Moved By Traders on 'Fast Money: Halftime Report'
CNBC's "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases in the coming months
Jaimy Lee The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week The U.S. is gearing up for another wave of COVID-19 infection
FDA Recommends Adding New Omicron Subvariants to COVID Boosters
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subvariants.
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter
Jaimy Lee The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week The U.S. is gearing up for another wave of COVID-19 infection
EMA Preliminary Data Indicate Adapted mRNA Vaccines, Which Incorporate An Omicron Variant Strain, Can Increase, Extend Protection, When Used As A Booster
EMA Preliminary Data Indicate Adapted mRNA Vaccines, Which Incorporate An Omicron Variant Strain, Can Increase, Extend Protection, When Used As A Booster
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
The FDA's independent experts voted to include a SARS-CoV-2 omicron component in COVID-19 vaccines that would be used for boosters in the U.S. beginning in fall 2022.The panel has advised manufacturer
Global HER2 Inhibitors Market Report (2022 to 2031) - Featuring Novartis, Pfizer and Puma Biotechnology Among Others
Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2022: By Treatment, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior mana
Loading...
No Stock Yet